Trine Jepsen

Title: Trine Jepsen: Innovator in Diabetes Treatment

Introduction

Trine Jepsen is a notable inventor based in Copenhagen, Denmark. She has made significant contributions to the field of diabetes treatment through her innovative research and development. Her work focuses on the stabilization of Exendin-4 compounds, which are crucial for managing diabetes.

Latest Patents

Trine Jepsen holds a patent for "Stabilized Exendin-4 compounds." This invention discloses compositions comprising a stabilized Exendin-4 (1-39) and related compounds. The patent describes stabilized Exendin-4 agonists that include at least one modified amino acid residue, particularly at positions Gln 13, Met14, Trp25, or Asn28 of the Exendin-4 (1-39) molecule. The preferred modifications include deaminated, hydrolyzed, oxidized, or isomerized reaction products of the specified amino acid residues. The invention also relates to methods of making and using the stabilized Exendin compounds for the treatment of diabetes. Trine Jepsen has 1 patent to her name.

Career Highlights

Trine Jepsen is associated with Zealand Pharma A/S, a company dedicated to developing innovative therapies for diabetes and other serious diseases. Her work at Zealand Pharma has been instrumental in advancing the understanding and treatment of diabetes through her patented inventions.

Collaborations

Trine has collaborated with notable colleagues, including Kirsten Ebbehøj and Bjarne Due Larsen. These collaborations have further enhanced her research and development efforts in the field of diabetes treatment.

Conclusion

Trine Jepsen is a pioneering inventor whose work on stabilized Exendin-4 compounds has the potential to significantly impact diabetes treatment. Her contributions to the field exemplify the importance of innovation in healthcare.